Close Window
Aetna
Aetna Aetna
Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Relistor

Status Drug PR PR-QL PR-AL ST M EX‡
P Relistor®  (methylnaltrexone bromide injection) X X      


Policy:

  1. Precertification Criteria
  2. Under some plans, including plans that use an open or closed formulary, Relistor is subject to precertification. If precertification requirements apply Aetna considers Relistor to be medically necessary for those members who meet the following precertification criteria:

    A documented:

    A. Diagnosis of opioid-induced constipation

    AND

    B. Diagnosis of an advanced illness with life expectancy less than 6 months*

    AND

    C. Concomitant use of opioid therapy**

    AND

    D. Trial and failure of two (2) laxatives***

    AND

    E. A quantity of Relistor as indicated below will be considered medically necessary, if Member fulfills criteria A, B, C, and D above:

    Drug Maximum Daily Dose/ Dosing Interval Dosage Strength Quantity Limits
    Relistor 12 mg/ Once daily 12mg/0.6mL Up to 10 vials per 30 days
    Relistor Kit 12 mg/ Once daily 12mg/0.6mL 1 kit (7 syringes) per 30 days


    For coverage of additional quantities, a member's treating physician must request prior authorization through the Pharmacy Management Precertification Unit. Additional quantities of Relistor will be considered medically necessary for those members who meet ANY of the following criteria:

    • Member requires dosing of one vial/syringe every other day (maximum quantity of 15 vials or 2 kits per 30 days).
    • Member's physician provides documentation (controlled clinical trial) from the peer-reviewed medical literature for use of a higher dose.



Special Notes:

*Advanced illness can be associated with diagnoses of incurable cancer, end-stage COPD/emphysema, cardiovascular disease/heart failure, Alzheimer’s disease/dementia, HIV/AIDS, or other advanced illness with a life expectancy of less than 6 months.

**Examples of opioid therapy – any single entity or combination product containing any of the following: codeine, fentanyl, hydrocodone, hydromorphone, meperidine, methadone, morphine, oxycodone, oxymorphone, propoxyphene or tramadol. Please refer to the Analgesics CPB: http://aetnet.aetna.com/pharmacy_pcpb/rxnonmedicare/data/2009/CNS2009/narcotic-analgesics_2009.html

***Examples of laxatives –
Generic                                      Brand
Bisacodyl                                   Alphen, Bisac-Evac, Biscolax, Correctol, Dacodyl, Doxidan, Dulcolax,
                                                 Ex-Lax, Femilax, Fleet
Glycerin                                     Colace, Fleet, Sani-Supp
Lactulose                                   Constulose, Enulose, Generlac, Kristalose
Magnesium citrate                      Citroma
Magnesium hydroxide                 Phillips’ Milk of Magnesia
Polyethylene glycol 3350             Miralax
Senna                                        Ex-lax, Perdiem, Peri-Colace, Senna-Gen, Senokot, SenoSol
Sodium phosphate                      Fleet, OsmoPrep, Visicol
Sorbitol



Place of Service:

Outpatient

The above policy is based on the following references:

1. DrugPoints® System ( www.statref.com) Thomson Micromedex, Greenwood Village, CO. Updated periodically.
2. AHFS Drug Information® with AHFSfirstReleases®. ( www.statref.com), American Society Of Health-System Pharmacists®, Bethesda, MD. Updated periodically.
3. DRUGDEX® System [Internet database]. Greenwood Village, Colo: Thomson Micromedex. Updated periodically.
4. Drug Facts and Comparisons on-line. (www.drugfacts.com), Wolters Kluwer Health, St. Louis, MO. Updated periodically.
5. PDR® Electronic Library™ [Internet database]. Greenwood Village, Colo: Thomson Micromedex. Updated periodically.
6. Relistor® Product Information. Wyeth, Philadelphia, PA, April 2008.

Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.

August 15, 2009
email this page   
Aetna
Skip Past Footer Links
Company Information   |   Site Map Aetna.com Home   |   Help   |   Contact Us   |   Search
Web Privacy Statement   |   Legal Statement   |   Privacy Notices   |   Member Disclosure

Back to top